Cite
Treatment patterns and hospitalizations following rejection, reversal, or payment of the initial once-monthly paliperidone palmitate long-acting injectable antipsychotic claim among patients with schizophrenia or schizoaffective disorder.
MLA
Benson, Carmela, et al. “Treatment Patterns and Hospitalizations Following Rejection, Reversal, or Payment of the Initial Once-Monthly Paliperidone Palmitate Long-Acting Injectable Antipsychotic Claim among Patients with Schizophrenia or Schizoaffective Disorder.” Journal of Managed Care & Specialty Pharmacy, vol. 30, no. 9, Sept. 2024, pp. 954–66. EBSCOhost, https://doi.org/10.18553/jmcp.2024.23252.
APA
Benson, C., Patel, C., Lee, I., Shaikh, N. F., Wang, Y., Zhao, X., & Near, A. M. (2024). Treatment patterns and hospitalizations following rejection, reversal, or payment of the initial once-monthly paliperidone palmitate long-acting injectable antipsychotic claim among patients with schizophrenia or schizoaffective disorder. Journal of Managed Care & Specialty Pharmacy, 30(9), 954–966. https://doi.org/10.18553/jmcp.2024.23252
Chicago
Benson, Carmela, Charmi Patel, Inyoung Lee, Nazneen Fatima Shaikh, Yi Wang, Xiaohui Zhao, and Aimee M Near. 2024. “Treatment Patterns and Hospitalizations Following Rejection, Reversal, or Payment of the Initial Once-Monthly Paliperidone Palmitate Long-Acting Injectable Antipsychotic Claim among Patients with Schizophrenia or Schizoaffective Disorder.” Journal of Managed Care & Specialty Pharmacy 30 (9): 954–66. doi:10.18553/jmcp.2024.23252.